欢迎来到天天文库
浏览记录
ID:46277951
大小:85.50 KB
页数:11页
时间:2019-11-22
《9例确诊非HIV患者肺孢子菌肺炎临床分析》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、9例确诊非HIV患者肺胞子菌肺炎临床分析[摘要]目的探讨非HIV免疫功能抑制患者肺胞子菌肺炎(PCP)的临床特点。方法回顾性分析9例非HIV免疫功能抑制患者肺砲子菌肺炎患者的临床资料。结果所有患者发生PCP前均接受了长期激素或免疫抑制剂治疗,其中8例(88.9%)应用糖皮质激素,3例(33.3%)接受免疫抑制剂治疗。所有患者均存在进行性呼吸困难,7例(77.8%)出现典型三联征”“发热、干咳和进行性呼吸困难。影像学特征为双肺弥漫磨玻璃浸润影8例(88.9%)和实变影1例(11.1%)O7例患者应用磺胺甲恶吐/甲氧节噪联合卡泊芬净治疗,死亡2例;2例患者应用磺胺甲恶哇/
2、甲氧节唳治疗,死亡1例;总病死率33.3%o结论非HIV免疫功能抑制患者感染PCP病死率较高,对有出现发热、干咳和进行性呼吸困难及双肺弥漫磨玻璃浸润影等临床表现的患者,尤其是免疫功能受损时应考虑PCP的可能,及早进行痰或支气管肺泡灌洗液病原学检查,以早期诊断、早期治疗。[关键词]肺胞子菌肺炎;非获得性免疫缺陷综合征;临床特点;G试验[中图分类号]R563.1[文献标识码]B[文章编号]1673-9701(2016)21-0033-03[Abstract]ObjectiveToinvestigatetheclinicalcharacteristicsofPneumocy
3、stispneumoniapatientswithnon-humanimmunodeficiencyvirus(non~HIV).Methods9patientswithconfirmednon-HIVPCPwereretrospectivelyanalyzed.ResultsAllthepatientsreceivedcorticosteroidtherapyandimmunosuppressivetherapiesbeforetheyhadthePCP,inwhich8patients(88.9%)usedcorticosteroidtherapyandthree
4、patients(33・3%)acceptedimmunosuppressivetherapy.Allthepatientshadthesymptomofprogressivedyspnea,inwhichsevenpatients(77.8%)appearedtypicaltriad:fever,drycoughandprogressivedyspnea.Eightpatients(88.9%)CTshoweddiffuseground-glassopacityandonepatient(11.1%)showedconsolidationindoublelungs・
5、Sevenpatientsweretreatedwithtrimethoprim-sulfamethoxozolcombiningwithcaspofungininwhichtwopatientsdied.Twopatientsweretreatedwithtrimethoprim-sulfamethoxazolinwhichonepatientdied.Thetotalmortalityratewas33.3%.ConclusionThemortalityofnon-HIVimmunosuppressedpatientswithPCPishigh.Patientsw
6、hohavesymptomsoffever,drycoughandprogressivedyspneatogetherwithdiffuseground-glassopacityindoublelungsshouldbesuspectedwithofPCP,especiallyinimmunosuppressivepatients.Thepathogenicexaminationofsputumorbronchoalveolarlavagefluidsshouldbetakenassoonaspossibleinordertoearlydiagnosisandearl
7、ytreatment.[Keywords]Pneumocystispneumonia;Non-humanimmunodeficiencyvirus;Clinicalfeature;Gtest肺鞄子菌肺炎(pneumocystispneumonia,PCP)是由卡氏肺砲子菌感染引起的肺部非化脓性间质性炎症,为一种呼吸系统严重的机会感染性疾病,是艾滋病(AIDS)患者常见的机会感染和主要的致死原因之一。近些年,PCP在其他免疫功能抑制患者,如移植、恶性肿瘤放化疗、结缔组织病及长期应用激素及免疫抑制剂患者中发病率逐渐增加[1-4]o本病在非AIDS免疫抑制
此文档下载收益归作者所有